What is Kivira?
Kivira operates at the intersection of artificial intelligence and clinical psychiatry, providing a sophisticated platform designed to augment mental health diagnosis within primary care environments. By utilizing structured clinical assessments and evidence-based guidelines, the company empowers clinicians to achieve higher diagnostic accuracy and more informed treatment planning. The platform is engineered to streamline complex medical workflows, ensuring that healthcare professionals remain the central authority in patient care decisions while benefiting from data-driven insights.
The company's market position is defined by its commitment to evidence-based medicine, distinguishing it from purely algorithmic competitors. By focusing on the primary care physician as the primary user, Kivira addresses a critical bottleneck in the healthcare system: the timely and accurate identification of mental health conditions before they escalate into more severe clinical challenges.
How much funding has Kivira raised?
Kivira has raised a total of $1.8M across 1 funding round:
Angel/Pre-Seed
$1.8M
Angel/Pre-Seed (2026): $1.8M with participation from WellStar Health System
Key Investors in Kivira
WellStar Health System
WellStar is a prominent not-for-profit health system operating a comprehensive network of hospitals, physician groups, and specialized care centers, focused on advancing patient outcomes through clinical innovation.
What's next for Kivira?
Looking ahead, the strategic deployment of the $1.8M will likely focus on expanding the platform's clinical validation studies and enhancing its integration capabilities with existing electronic health record systems. As the company transitions from its current development phase toward broader commercialization, the focus will shift to scaling its sales and implementation teams to support health systems nationwide.
The long-term growth trajectory for Kivira involves deepening its diagnostic capabilities through machine learning refinements and potentially expanding its therapeutic support modules. With the backing of strategic partners, the company is poised to become a standard-bearer for AI-assisted mental health care, effectively bridging the gap between diagnostic complexity and clinical efficiency in the primary care landscape.
